TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
GNTA

Genenta Science SpA

Healthcare · Biotechnology

0.6903$ +0.7% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement GNTA
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– – +188.2% +17.7% +595.5% +11.5% -42.0%
– – – – – – –
– +19.5% -19.0% +47.5% +22.0% -21.0% -48.4%
– -2.1% +154.7% +148.4% -7.8% -5.8% -21.1%
– +14.1% +13.9% +82.0% +6.5% -11.6% -37.8%
– – – – – – –
– -18.8% +51.1% +21,803.6% – – –
– – – – – – –
– +43.6% +128.7% -15,568.5% – – –
– – – – – – –
– – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?